Mr. Morris most recently served as executive vice president of mergers & acquisitions of Marathon Pharmaceuticals. Prior to that, Mr Morris served as vice president of legal affairs and general counsel of Lundbeck, Inc. (formerly Ovation Pharmaceuticals), a multinational biopharmaceutical company.
Mr. Morris also served as vice president of legal affairs and general counsel of Ovation Pharmaceuticals from 2003 through March, 2009, when a deal team led by Mr. Morris completed its acquisition by H. Lundbeck A/S.
Prior to joining Ovation Pharmaceuticals, Mr. Morris was a partner at the national law firm Katten Muchin Rosenman LLP, where he worked, among other things, on the firm’s merger with Rosenman and Colin LLP and as Ovation Pharmaceuticals’ primary outside legal counsel from its inception.
Mr. Morris has almost 20 years of legal experience, with a primary expertise in pharmaceuticals/biologics, venture capital, private equity, mergers, acquisitions, divestitures, licensing transactions and corporate law.
He received his J.D. from Northwestern University School of Law and a bachelor’s degree from DePaul University.